| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Absence of lobular carcinoma in situ is a poor prognostic marker in invasive lobular carcinoma
|
Mouabbi, Jason A.
|
|
|
191 |
C |
p.
|
artikel
|
| 2 |
Actionable molecular alterations in newly diagnosed and recurrent IDH1/2 wild-type glioblastoma patients and therapeutic implications: a large mono-institutional experience using extensive next-generation sequencing analysis
|
Padovan, Marta
|
|
|
191 |
C |
p.
|
artikel
|
| 3 |
Acute kidney injury in patients receiving immune checkpoint inhibitors: a retrospective real-world study
|
Lumlertgul, Nuttha
|
|
|
191 |
C |
p.
|
artikel
|
| 4 |
Adjuvant treatment and outcome of stage III melanoma patients: Results of a multicenter real-world German Dermatologic Cooperative Oncology Group (DeCOG) study
|
Lodde, Georg C.
|
|
|
191 |
C |
p.
|
artikel
|
| 5 |
A phase II randomised controlled trial of adjuvant tumour-infiltrating lymphocytes for pretreatment Epstein-Barr virus DNA-selected high-risk nasopharyngeal carcinoma patients
|
Liang, Yu-Jing
|
|
|
191 |
C |
p.
|
artikel
|
| 6 |
Association of body mass index with clinicopathological features and survival in patients with primary invasive lobular breast cancer
|
Van Baelen, Karen
|
|
|
191 |
C |
p.
|
artikel
|
| 7 |
Associations of 25-hydroxyvitamin D status and vitamin D supplementation use with mortality due to 18 frequent cancer types in the UK Biobank cohort
|
Sha, Sha
|
|
|
191 |
C |
p.
|
artikel
|
| 8 |
DNA methylation markers in the detection of hepatocellular carcinoma
|
Fu, Siyu
|
|
|
191 |
C |
p.
|
artikel
|
| 9 |
Efficacy and safety of crizotinib in ALK-positive systemic anaplastic large-cell lymphoma in children, adolescents, and adult patients: results of the French AcSé-crizotinib trial
|
Brugières, Laurence
|
|
|
191 |
C |
p.
|
artikel
|
| 10 |
Faecal microbiota composition is related to response to CDK4/6-inhibitors in metastatic breast cancer: A prospective cross-sectional exploratory study
|
Schettini, Francesco
|
|
|
191 |
C |
p.
|
artikel
|
| 11 |
Italian nivolumab Expanded Access Programme in melanoma adjuvant setting: patient outcomes and safety profile
|
Ascierto, Paolo A.
|
|
|
191 |
C |
p.
|
artikel
|
| 12 |
Letter Re: Association between endocrine therapy and cognitive decline in older women with early breast cancer: Findings from the prospective CLIMB study
|
Chen, Hao
|
|
|
191 |
C |
p.
|
artikel
|
| 13 |
Letter Re: Response to checkpoint inhibition and targeted therapy in melanoma patients with concurrent haematological malignancies
|
Yang, Fan
|
|
|
191 |
C |
p.
|
artikel
|
| 14 |
Parental occupational exposure to metals and risk of cancer in the offspring: A register-based case-control study from Sweden
|
Rossides, Marios
|
|
|
191 |
C |
p.
|
artikel
|
| 15 |
Phase Ia dose-escalation trial with the BET protein inhibitor BI 894999 in patients with advanced or metastatic solid tumours
|
Schöffski, Patrick
|
|
|
191 |
C |
p.
|
artikel
|
| 16 |
Phase Ib/II trial of tipapkinogene sovacivec, a therapeutic human papillomavirus16-vaccine, in combination with avelumab in patients with advanced human papillomavirus16-positive cancers
|
Borcoman, Edith
|
|
|
191 |
C |
p.
|
artikel
|
| 17 |
Practical guidelines for the management of adverse events of the T cell engager bispecific tebentafusp
|
Hassel, Jessica C.
|
|
|
191 |
C |
p.
|
artikel
|
| 18 |
Preoperative chemotherapy prior to primary tumour resection for asymptomatic synchronous unresectable colorectal liver-limited metastases: The RECUT multicenter randomised controlled trial
|
Lin, Qi
|
|
|
191 |
C |
p.
|
artikel
|
| 19 |
Prognostic implications of HER2 changes after neoadjuvant chemotherapy in patients with HER2-zero and HER2-low breast cancer
|
Kang, Sora
|
|
|
191 |
C |
p.
|
artikel
|
| 20 |
Re: Hydrocortisone to reduce dexamethasone-induced neurobehavioral side-effects in children with acute lymphoblastic leukaemia—results of a double-blind, randomised controlled trial with cross-over design
|
Zhang, Dan
|
|
|
191 |
C |
p.
|
artikel
|
| 21 |
Response to letter entitled: Re: Association between endocrine therapy and cognitive decline in older women with early breast cancer: Findings from the prospective CLIMB study
|
Baltussen, Joosje C.
|
|
|
191 |
C |
p.
|
artikel
|
| 22 |
Response to letter entitled: Re: Hydrocortisone to reduce dexamethasone-induced neurobehavioral side-effects in children with acute lymphoblastic leukaemia—results of a double-blind, randomised controlled trial with cross-over design
|
van Hulst, Annelienke M.
|
|
|
191 |
C |
p.
|
artikel
|
| 23 |
Response to letter Re: Response to checkpoint inhibition and targeted therapy in melanoma patients with concurrent haematological malignancies
|
van Not, Olivier J.
|
|
|
191 |
C |
p.
|
artikel
|
| 24 |
Survival and modelled cancer antigen-125 ELIMination rate constant K score in ovarian cancer patients in first-line before poly(ADP-ribose) polymerase inhibitor era: A Gynaecologic Cancer Intergroup meta-analysis
|
Corbaux, Pauline
|
|
|
191 |
C |
p.
|
artikel
|
| 25 |
Therapy-related myeloid neoplasm in early breast cancer patients treated with adjuvant chemotherapy
|
Lee, Ji Won
|
|
|
191 |
C |
p.
|
artikel
|
| 26 |
Transcriptional intra-tumour heterogeneity predicted by deep learning in routine breast histopathology slides provides independent prognostic information
|
Wang, Yinxi
|
|
|
191 |
C |
p.
|
artikel
|
| 27 |
Trends in the epidemiology of small-cell lung cancer: a Dutch nationwide population-based study over 1989–2020
|
Dumoulin, Daphne W.
|
|
|
191 |
C |
p.
|
artikel
|
Tijdschrift beschrijving